<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29771306</article-id>
<article-id pub-id-type="pmc">6061782</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddy186</article-id>
<article-id pub-id-type="publisher-id">ddy186</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Invited Reviews</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Drug screening for human genetic diseases using iPSC models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Elitt</surname>
<given-names>Matthew S</given-names>
</name>
<xref ref-type="aff" rid="ddy186-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barbar</surname>
<given-names>Lilianne</given-names>
</name>
<xref ref-type="aff" rid="ddy186-aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tesar</surname>
<given-names>Paul J</given-names>
</name>
<xref ref-type="corresp" rid="ddy186-cor1"></xref>
<!--<email>paul.tesar@case.edu</email>-->
<xref ref-type="aff" rid="ddy186-aff1"></xref>
</contrib>
</contrib-group>
<aff id="ddy186-aff1">Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH, USA</aff>
<author-notes>
<corresp id="ddy186-cor1">To whom correspondence should be addressed. Tel: +1 216 368 6225; Fax: +1 216 368 3432; Email: <email>paul.tesar@case.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2018</year>
</pub-date>
<pub-date iso-8601-date="2018-05-16" pub-type="epub">
<day>16</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2019</year>
</pub-date>
<!-- PMC Release delay is 12 months and
						0 days and was based on the <pub-date
						pub-type="ppub"/>. -->
<volume>27</volume>
<issue>R2</issue>
<fpage>R89</fpage>
<lpage>R98</lpage>
<history>
<date date-type="received">
<day>26</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>26</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>10</day>
<month>5</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Â© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="oup-standard" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">
<license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/journals/pages/about_us/legal/notices">https://academic.oup.com/journals/pages/about_us/legal/notices</ext-link>)</license-p>
</license>
</permissions>
<self-uri xlink:href="ddy186.pdf"></self-uri>
<abstract>
<title>Abstract</title>
<p>Induced pluripotent stem cells (iPSCs) enable the generation of previously unattainable, scalable quantities of disease-relevant tissues from patients suffering from essentially any genetic disorder. This cellular material has proven instrumental for drug screening efforts on these disorders, and has facilitated the identification of novel therapeutics for patients. Here we will review the foundational technologies that have enabled iPSCs, the power and limitations of iPSC-based compound screens along with screening guidelines, and recent examples of screening efforts. Additionally we will provide a brief commentary on the future scientific roadmap using pluripotent- and 3D organoid-based, combinatorial approaches.</p>
</abstract>
<funding-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">NIH</named-content>
<named-content content-type="funder-identifier">10.13039/100000002</named-content>
</funding-source>
<award-id>R01NS093357</award-id>
<award-id>R01NS095280</award-id>
<award-id>T32GM007250</award-id>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">New York Stem Cell Foundation</named-content>
<named-content content-type="funder-identifier">10.13039/100003194</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">National Multiple Sclerosis Society</named-content>
<named-content content-type="funder-identifier">10.13039/100000890</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">Pelizaeus Merzbacher Disease Foundation</named-content>
</funding-source>
</award-group>
<award-group award-type="grant">
<funding-source>
<named-content content-type="funder-name">European Leukodystrophy Association</named-content>
<named-content content-type="funder-identifier">10.13039/501100008731</named-content>
</funding-source>
</award-group>
</funding-group>
<counts>
<page-count count="10"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>